Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, 'Eve') and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay

Journal of Chromatography B: Biomedical Applications

Volumn 683, Issue 2, 1996, Pages 189-197

  Ensslin, Hartmut K ^a   Kovar, Karl Artur ^a   Maurer, Hans H ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

3,4 Methylenedioxyethylamphetamine; Fluorescence polarization immunoassay; Mass spectrometry

Indexed keywords

DESIGNER DRUG; DRUG METABOLITE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE;

ACETYLATION; ARTICLE; CONTROLLED STUDY; EXTRACTION; FLUORESCENCE POLARIZATION IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROLYSIS; INTERMETHOD COMPARISON; MALE; MASS SPECTROMETRY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TECHNIQUE; URINALYSIS;

EID: 0030606825     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(96)00129-6     Document Type: Article

References (39)

1. [1] H.H. Maurer, H. Ensslin and K.-A. Kovar, Abstract Book to EUROTOX '91, Annual Meeting of the European Society of Toxicology, Maastricht, September 1991, p. 286.
2. [2] U. Braun, A.T. Shulgin and G. Braun, J. Pharm. Sci., 69 (1980) 192.
3. [3] E. Gouzoulis, A. Steiger, H.K. Ensslin, K.-A. Kovar and L. Hermle, Biol. Psych., 32 (1992) 1108.
4. [4] E. Gouzoulis, U.v. Bardeleben, A. Rupp, K.-A. Kovar and L. Hermle, Neuropsychopharmacology, 8 (1993) 187.
5. [5] L. Hermle, M. Spitzer, D. Borchardt, K.-A. Kovar and E. Gouzoulis, Neuropsychopharmacology, 8 (1993) 171.
6. [6] D.E. Nichols, J. Psychoactive Drugs, 18 (1986) 305.
7. [7] R.G. Greer and R. Tolbert, in S.J. Peroutka (Editor), Ecstasy: the Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA, Kluwer Academic Publishers, Dordrecht, 1990, p. 21.
8. [8] D.M. Stone, M. Johnson, G.R. Hanson and J.W. Gibb, Eur. J. Pharmacol., 134 (1987) 245.
9. [9] D.L. Commins, G. Vosmer, R.M. Virus, W.L. Woolverton, C.R. Schuster and L.S. Seiden, J. Pharmacol, Exp. Ther., 241 (1987) 338.
10. [10] T.R. Insel, G. Battaglia, J.N. Johannessen, S. Marra and E.B. De Souza, J. Pharmacol. Exp. Ther., 249 (1989) 713.
11. [11] M. Johnson, I. Elayan, G.R. Hanson, R.L. Foltz, J.W. Gibb and H.K. Lim, J. Pharmacol. Exp. Ther., 261 (1992) 447.
12. [12] G.A. Ricaurte and U.D. McCann, Ann. N.Y. Acad. Sci., 648 (1992) 371.
13. [13] J. Brodkin, A. Malyala and J.F. Nash, Pharmacol. Biochem. Behav., 45 (1993) 647.
14. [14] S.F. Ali, G.D. Newport, A.C. Scallet, Z. Binienda, S.A. Ferguson, J.R. Bailey, M.G. Paule and W. Slikker Jr., Neurotoxicol. Teratol., 15 (1993) 91.
15. [15] M. Johnson, G.R. Hanson and J.W. Gibb, Biochem. Pharmacol., 38 (1989) 4333.
16. [16] C. Singarajah and N.G. Lavies, Anaesthesia, 47 (1992) 686.
17. [17] P. McGuire and T. Fahy, J. Psychiatry, 160 (1992) 276.
18. [18] J.A. Henry, K.J. Jeffreys and S. Dawling, Lancet, 340 (1992) 384.
19. [19] G.P. Dowling, E.T. McDonough III and R.O. Bost, JAMA, 257 (1987) 1615.
20. [20] E. Gouzoulis, D. Borchardt and L. Hermle, Arch. Gen. Psychiatry, 50 (1993) 75.
21. [21] M.T. Cregg and J.A. Tracey, Ir. Med. J., 86 (1993) 118.
22. [22] S. Manchada and M.J. Connolly, Postgrad. Med. J., 69 (1993) 874.
23. [23] J.T. Cody, J. Anal. Toxicol., 14 (1990) 321.
24. [24] G.W. Kunsman, J.E. Manno, K.R. Cockerham and B.R. Manno, J. Anal. Toxicol., 14 (1990) 149.
25. [25] A. Poklis, R.L. Fitzgerald, K.V. Hall and J.J. Saady, Forensic Sci. Int., 59 (1993) 63.
26. [26] J.T. Cody and R. Schwarzhoff, J. Anal. Toxicol., 17 (1993) 26.
27. [27] H.H. Maurer and T. Kraemer, Arch. Toxicol., 66 (1992) 675.
28. [28] L. Tedeschi, G. Frison, F. Castagna, R. Giorgetti and S.D. Ferrara, Int. J. Legal Med., 1058 (1993) 265.
29. [29] H.J. Helmlin and R. Brenneisen, J. Chromatogr., 593 (1992) 87.
30. [30] R.E. Michel, A.B. Rege and W.J. George, J. Neurosci. Methods, 50 (1993) 61.
31. [31] H.K. Ensslin, H.H. Maurer, E. Gouzoulis, L. Hermle and K.-A. Kovar, Drug Metab. Dispos., 24 (1996), in press.
32. [32] K. Pfleger, H.H. Maurer and A. Weber, Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, Hewlett Packard, Palo Alto, CA, 2nd rev., 1993.
33. [33] E. Kovats, Helv. Chim. Acta, 41 (1958) 1915.
34. [34] Deutsche Forschungsgemeinschaft, Senatskommission für Klinisch-toxikologische Analytik, J. Clin. Chem. Clin. Biochem., 20 (1982) 699.
35. [35] R.A. De Zeeuw, J.P. Franke, H.H. Maurer and K. Pfleger, Gas Chromatographic Retention Indices of Toxicologically Relevant Substances and their Metabolites (Report of the DFG commission for clinical toxicological analysis, special issue of the TIAFT bulletin), VCH publishers, Weinheim, New York, Basle, 3rd ed., 1992.
36. [36] H.H. Maurer, J. Chromatogr., 580 (1992) 3.
37. [37] G.B. Baker, R.T. Coutts and A. Holt, J. Pharmacol. Toxicol. Meth., 31 (1994) 141.
38. [38] K. Pfleger, H.H. Maurer and A. Weber, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites, VCH publishers, Weinheim, New York, Basle, 2nd ed., 1992.
39. [39] H.H. Maurer, T. Kraemer, O. Ledvinka, C.J. Schmitt and A.A. Weber, J. Chromatogr. B, in press.